Welcome to our dedicated page for TransDigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TransDigm Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TransDigm Group's regulatory disclosures and financial reporting.
TransDigm Group (TDG): Director Peter Palmer reported an equity grant on Form 4. He acquired stock options covering 518 shares on Nov 4, 2025 with an exercise price of $1,291.97 per share and an expiration date of Nov 4, 2035.
The options vest at 20% per year over five years, beginning Sept 30, 2026, and are subject to the achievement of annual operating performance targets each year. Following the transaction, 518 derivative securities were beneficially owned on a direct basis.
TransDigm Group (TDG) filed a Form 4 showing a director stock option grant. On 11/04/2025, a reporting person serving as a Director received stock options covering 518 shares at an exercise price of $1,291.97 per share. The options were reported as acquired (Code A) and are held directly.
The options expire on 11/04/2035 and vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets in each year.
TransDigm Group (TDG) reported that director Robert Small acquired 518 stock options on November 4, 2025 (Transaction Code A) with an exercise price of $1,291.97 per share and an expiration date of November 4, 2035.
The options vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets. Following the transaction, 518 derivative securities were beneficially owned, held directly.
TransDigm Group (TDG) reported an insider equity award. Director Kevin Stein acquired 518 stock options on 11/04/2025 with an exercise price of $1,291.97.
The options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets, and expire on 11/04/2035. Following the grant, 518 derivative securities were beneficially owned on a direct basis.
TransDigm Group (TDG) reported a Form 4 showing a grant of 26,450 stock options to a Co‑Chief Operating Officer at an exercise price of $1,291.97 on November 4, 2025.
The options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets, and expire on November 4, 2035. Following the transaction, 26,450 derivative securities were beneficially owned, held directly. Transaction code: A (award).
TransDigm Group (TDG) reported an insider equity award. Officer Armani Vadiee (GC, CCO, Secretary) received a grant of 17,100 stock options on 11/04/2025 at an exercise price of $1,291.97 per share. The options expire on 11/04/2035.
Per the grant terms, the options vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets each year. Following the reported transaction, 17,100 derivative securities were beneficially owned, held direct.
TransDigm Group (TDG) reported a Form 4 for CFO Sarah Wynne showing a grant of 8,700 stock options on 11/04/2025 with an exercise price of $1,291.97 per share.
The options vest 50% in 2029 and 50% in 2030, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. The filing lists direct ownership.
TransDigm Group (TDG) reported a Form 4 for Co‑Chief Operating Officer Joel Reiss, reflecting a grant of stock options for 9,700 shares at an exercise price of $1,291.97 on 11/04/2025.
The options expire on 11/04/2035 and are scheduled to vest 50% in 2029 and 50% in 2030, subject to achieving annual operating performance targets in each year. Following the grant, 9,700 derivative securities are beneficially owned on a direct basis.
TransDigm Group (TDG) disclosed a Form 4 showing its President & CEO, Michael Lisman, received stock option grants on 11/04/2025. Two awards were reported with an exercise price of $1,291.97 and an expiration of 11/04/2035 (Transaction Code: A). The first grant covers 75,696 options; the second covers 3,907 options. Both were acquired at $0 for the derivative security and are listed as Direct (D) ownership.
Vesting is performance-based: the 75,696 options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets. The 3,907 options vest 80% in 2026 and 20% in 2027, subject to similar targets.
TransDigm Group (TDG) director filed an initial ownership report (Form 3) for an event on 10/23/2025.
The filing lists 4,000 shares of common stock (direct) and multiple stock options. Notable grants include 22,100 options at $559.78 (exercisable 09/30/2023, expiring 11/15/2029) and 17,160 options at $643 (exercisable 09/30/2025, expiring 11/12/2031). Additional options include 2,600 at $582.8 and 4,730 at $869.73.
Some options are held indirectly by a Family Trust (3,000 and 2,375 options at $476.81, expiring 04/25/2029). The report notes it was filed late by 2 days due to administrative delays.